3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Breast Neoplasms
222
Carcinoma, Non-Small-Cell Lung
219
Prostatic Neoplasms
156
Multiple Myeloma
142
Neoplasms
133
Colorectal Neoplasms
118
Leukemia, Myeloid, Acute
110
Lung Neoplasms
103
Neoplasm Metastasis
96
Squamous Cell Carcinoma of Head and Neck
91
Carcinoma, Hepatocellular
86
Lymphoma
81
Melanoma
78
Pancreatic Neoplasms
74
Triple Negative Breast Neoplasms
72
Ovarian Neoplasms
66
Sarcoma
65
Lymphoma, Large B-Cell, Diffuse
61
Carcinoma, Renal Cell
61
Brain Neoplasms
58
Precursor Cell Lymphoblastic Leukemia-Lymphoma
57
Head and Neck Neoplasms
57
Recurrence
56
Lymphoma, Non-Hodgkin
55
Stomach Neoplasms
53
Leukemia, Lymphocytic, Chronic, B-Cell
52
Hematologic Neoplasms
52
Endometrial Neoplasms
50
Small Cell Lung Carcinoma
48
Urinary Bladder Neoplasms
46
Interventions
vedolizumab
1
Photopheresis
1
Mycophenolic Acid
1
Methoxsalen
1
Infliximab
1
Azathioprine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Hepatitis
×
90 days
×
Clear all
NCT07619898
2026-06-02
PHOENIX-ECP
Therakos LLC
Phase 2
Not yet recruiting
112 enrolled